|
1
|
Priola AM and Priola SM: Imaging of thymus
in myasthenia gravis: from thymic hyperplasia to thymic tumor. Clin
Radiol. 65:e230–e245. 2014. View Article : Google Scholar
|
|
2
|
Shapiro M and Korst RJ: Surgical
approaches for stage IVA thymic epithelial tumors. Front Oncol.
3:3322014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Engels EA: Epidemiology of thymoma and
associated malignancies. J Thorac Oncol. 5(10 Suppl 4): S260–S265.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lucchi M, Ricciard R, Melfi F, et al:
Association of thymoma and myasthenia gravis: oncological and
neurological results of the surgical treatment. Eur J Cardiothorac
Surg. 35:812–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu L, Zhang XJ, Ma S, et al: Different
characteristics of thymomas with and without myasthenia gravis. Ann
Surg Oncol. 19:94–98. 2012. View Article : Google Scholar
|
|
6
|
Zheng K, Xu G, Lu X, et al: Expression and
polymorphisms of T cell immunoglobulin domain and mucin domain
protein-1 in thymoma with or without myasthenia gravis. Oncol Lett.
8:317–322. 2014.PubMed/NCBI
|
|
7
|
Pearse G: Normal structure, function and
histology of the thymus. Toxicol Pathol. 34:504–514. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Wang W, Chen Y and Wei D: T helper
type 17 cells expand in patients with myasthenia-associated
thymoma. Scand J Immunol. 76:54–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zagoriti Z, Kambouris ME, Patrinos GP, et
al: Recent advance in genetic predisposition of myasthenia gravis.
Biomed Res Int. 2013:4040532013. View Article : Google Scholar
|
|
10
|
Zheng K, Zhang J, Guo Y and Zhang P:
Expression and clinical significance of protein tyrosine
phosphatase nonreceptor 22 in resected thymoma. Clin Lab.
59:1041–1044. 2013.PubMed/NCBI
|
|
11
|
Monney L, Sabatos CA, Gaglia JL, et al:
Th1-specific cell surface protein Tim-3 regulates macrophage
activation and severity of an autoimmune disease. Nature.
415:536–541. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu C, Anderson AC, Schubart A, et al: The
Tim-3 ligand galectin-9 negatively regulates T helper type 1
immunity. Nat Immunol. 6:1245–1252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson AC and Anderson DE: TIM-3 in
autoimmunity. Curr Opin Immunol. 18:665–669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sabatos CA, Chakravarti S, Cha E, et al:
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1
responses and induction of peripheral tolerance. Nat Immunol.
4:1102–1110. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mattei F and Schiavoni G: TIM-3 as a
molecular switch for tumor escape from innate immunity. Front
Immunol. 3:4182013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fourcade J, Sun Z, Benallaoua M, et al:
Upregulation of Tim-3 and PD-1 expression is associated with tumor
antigen-specific CD8+ T cell dysfunction in melanoma
patients. J Exp Med. 207:2175–2186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baitsch L, Baumgaertner P, Devêvre E, et
al: Exhaustion of tumor-specific CD8+ T cells in
metastases from melanoma patients. J Clin Inverst. 121:2350–2360.
2011. View
Article : Google Scholar
|
|
18
|
Sakuishi K, Apetoh L, Sullivan JM, et al:
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and
restore anti-tumor immunity. J Exp Med. 207:2187–2194. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Q, Munger ME, Veenstra RG, et al:
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell
exhaustion phenotype in mice with disseminated acute myelogenous
leukemia. Blood. 117:4501–4510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mclntire JJ, Umetsu SE, Macaubas C, et al:
Immunology: hepatitis A virus link to atopic disease. Nature.
425:5762003. View
Article : Google Scholar
|
|
21
|
Shen Y, Wang C, Hong D, et al: The
relationship between polymorphisms in the promoter region of Tim-3
and unexplained recurrent spontaneous abortion in Han Chinese
women. Reprod Biol Endocrinol. 11:1042013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shang Y, Li Z, Li H, et al: TIM-3
expression in human osteosarcoma: Correlation with the expression
of epithelial-mesenchymal transition-specific biomarkers. Oncol
Lett. 6:490–494. 2013.PubMed/NCBI
|
|
23
|
Freeman GJ, Casasnovas JM, Umetsu DT and
DeKruyff RH: TIM genes: a family of cell surface phosphatidylserine
receptors that regulate innate and adaptive immunity. Immunol Rev.
235:172–189. 2010.PubMed/NCBI
|
|
24
|
Koguchi K, Anderson DE, Yang L, et al:
Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp
Med. 203:1413–1418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meyers JH, Sabatos CA, Chakravarti S and
Kuchroo VK: The TIM gene family regulates autoimmune and allergic
diseases. Trends Mol Med. 11:362–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Yang Y, Liu X and Wang Y: The
-1541C>T and +4259G>T of TIM-3 polymorphisms are associated
with rheumatoid arthritis susceptibility in a Chinese Hui
population. Int J Immunogenet. 38:513–518. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piao YR, Piao LZ, Zhu LH, et al:
Prognostic value of T cell immunoglobulin mucin-3 in prostate
cancer. Asian Pac J Cancer Prev. 14:3897–3901. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao Y, Zhou X, Huang X, et al: Tim-3
expression in cervical cancer promotes tumor metastasis. PLoS One.
8:e538342013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai C, Wang L, Wu Z, et al: T-cell
immunoglobulin- and mucin-domain-containing molecule 3 gene
polymorphisms and renal cell carcinoma. DNA Cell Biol.
31:1285–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tong D, Zhou Y, Chen W, et al: T cell
immunoglobulin- and mucin-domain-containing molecule 3 gene
polymorphisms and susceptibility to pancreatic cancer. Mol Biol
Rep. 39:9941–9946. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang D and Lotze MT: Tumor immunity times
out: TIM-3 and HMGB1. Nat Immunol. 13:808–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
